Semaglutide (Wegovy) for the treatment of obesity or weight management should not be used during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm due to the potential hazard of maternal weight loss to the fetus
If your diet lacks B12 or you prefer not managing daily pills, injections could be more convenient, and vice versa
These are typically set to around 4 to 7 degrees Celsius, which falls within the acceptable storage range
The substance is safe for use in medicines according to ICH standards, and the quality is the same from one batch of production to the next
Archived from the original on February 6, 2013
Safety, Dangers, and Regulatory Considerations of AOD 9604 Safety, dangers, and regulatory considerations surrounding AOD 9604 remain areas of concern